TonEBP Haploinsufficiency Attenuates Microglial Activation and Memory Deficits in Middle-Aged and Amyloid β

Jong Youl Lee1,2, Eun Ae Jeong1, Jaewoong Lee1

  • 1Department of Anatomy and Convergence Medical Science, College of Medicine, Institute of Medical Science, Gyeongsang National University, Jinju 52727, Republic of Korea.

Cells
|November 24, 2023
PubMed

Insights

Tonicity-responsive enhancer-binding protein (TonEBP) drives age-related microglial activation and memory loss. Reducing TonEBP in middle-aged mice improved cognitive function and reduced neuroinflammation.

Area of Science:

  • Neuroscience
  • Immunology
  • Aging Research

Background:

  • Microglial activation increases with age and is linked to cognitive decline.
  • Tonicity-responsive enhancer-binding protein (TonEBP) mediates microglial responses to neuroinflammation.
  • The role of TonEBP in the aging brain remains unclear.

Purpose of the Study:

  • To investigate the role of TonEBP in age-related microglial activation and memory deficits.
  • To examine the impact of TonEBP haploinsufficiency on the middle-aged brain.
  • To assess the effect of TonEBP knockdown on amyloid-beta oligomer (AβO)-treated microglial cells.

Main Methods:

  • Utilized TonEBP haploinsufficient mice of varying ages (6, 12, and 24 months).
  • Administered amyloid-beta oligomers (AβO) to middle-aged mice and BV2 microglial cells.
  • Performed electron microscopy to analyze synaptic structures.
  • Assessed microglial activation, memory function, cell migration, and phagocytosis.

Main Results:

  • Hippocampal TonEBP expression increased with age.
  • TonEBP haploinsufficiency reduced microglial activation and memory deficits in middle-aged mice.
  • Synaptic pruning, dendritic spine loss, and memory impairments were ameliorated by reducing TonEBP in AβO-treated mice.
  • TonEBP knockdown decreased migration and phagocytosis in AβO-treated BV2 cells.

Conclusions:

  • TonEBP is a key mediator of age-related microglial activation.
  • TonEBP contributes to memory deficits associated with aging and neuroinflammation.
  • Targeting TonEBP may offer a therapeutic strategy for age-related cognitive impairment.

Related Concept Videos